Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy

Adriana Petronela Fildan (Constanta, Romania), Ariadna Petronela Fildan, Gheorghita Voicu, Livia Floca, Elis Curtmola, Elena Dantes

Source: International Congress 2015 – Screening strategies in TB
Session: Screening strategies in TB
Session type: Poster Discussion
Number: 2973
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Adriana Petronela Fildan (Constanta, Romania), Ariadna Petronela Fildan, Gheorghita Voicu, Livia Floca, Elis Curtmola, Elena Dantes. Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy. Eur Respir J 2015; 46: Suppl. 59, 2973

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Risk of developing active TB in children with latent TB infection
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


The risk of tuberculosis in HIV infected in the 12 years of observation
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013


The cases of active tuberculosis among persons with latent tuberculosis infection residing in the disease hot spots
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016

Increased incidence of TB disease within the health-care workers in an intermediate TB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016



Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Predictors of defaulting from treatment among patients with tuberculosis
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013


Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015

MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


Are the Roma population risk group for tuberculosis?
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013


Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Molecular epidemiological analysis of cases of pulmonary tuberculosis in patients with multiple admissions to TB hospital
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016